Healthcare provider profile · identity verified

Christopher J Cancro, MD

Family Practice · BILLINGS, MT · NPI 1275796997

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	316	92
Losartan Potassium	Losartan Potassium	302	88
Lisinopril	Lisinopril	246	73
Levothyroxine Sodium	Levothyroxine Sodium	233	64
Metoprolol Succinate	Metoprolol Succinate	209	59
Gabapentin	Gabapentin	201	54
Amlodipine Besylate	Amlodipine Besylate	193	60
Pantoprazole Sodium	Pantoprazole Sodium	177	49
Tamsulosin Hcl	Tamsulosin Hcl	164	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	138	28
Metformin Hcl Er	Metformin Hcl	122	34
Furosemide	Furosemide	119	29
Omeprazole	Omeprazole	117	28
Simvastatin	Simvastatin	117	30
Escitalopram Oxalate	Escitalopram Oxalate	110	35
Hydrochlorothiazide	Hydrochlorothiazide	109	35
Metformin Hcl	Metformin Hcl	108	34
Trazodone Hcl	Trazodone Hcl	99	26
Allopurinol	Allopurinol	85	21
Carvedilol	Carvedilol	78	23
Pravastatin Sodium	Pravastatin Sodium	75	20
Montelukast Sodium	Montelukast Sodium	74	22
Prednisone	Prednisone	74	42
Albuterol Sulfate Hfa	Albuterol Sulfate	73	25
Fluticasone Propionate	Fluticasone Propionate	71	24
Meloxicam	Meloxicam	70	22
Spironolactone	Spironolactone	68	18
Famotidine	Famotidine	67	17
Sertraline Hcl	Sertraline Hcl	65	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	20
Duloxetine Hcl	Duloxetine Hcl	60	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	16
Pioglitazone Hcl	Pioglitazone Hcl	60	15
Warfarin Sodium	Warfarin Sodium	60	11
Rosuvastatin Calcium	Rosuvastatin Calcium	58	17
Baclofen	Baclofen	56	11
Bupropion Xl	Bupropion Hcl	56	18
Propranolol Hcl	Propranolol Hcl	54	15
Eliquis	Apixaban	53	16
Oxycodone Hcl	Oxycodone Hcl	51	13
Azithromycin	Azithromycin	49	44
Clopidogrel	Clopidogrel Bisulfate	49	14
Ozempic	Semaglutide	49	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Tramadol Hcl	Tramadol Hcl	45	17
Fluoxetine Hcl	Fluoxetine Hcl	43	12
Zolpidem Tartrate	Zolpidem Tartrate	42	13
Jardiance	Empagliflozin	40	14
Atenolol	Atenolol	39	suppressed
Potassium Chloride	Potassium Chloride	39	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	13
Venlafaxine Hcl Er	Venlafaxine Hcl	38	11
Buspirone Hcl	Buspirone Hcl	37	11
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Celecoxib	Celecoxib	36	15
Mirtazapine	Mirtazapine	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	11
Ketoconazole	Ketoconazole	35	13
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	34	suppressed
Pregabalin	Pregabalin	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	11
Finasteride	Finasteride	27	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Nystatin	Nystatin	24	suppressed
Xarelto	Rivaroxaban	24	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	12
Valacyclovir	Valacyclovir Hcl	23	suppressed
Trulicity	Dulaglutide	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	17
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Linzess	Linaclotide	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Topiramate	Topiramate	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	11
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Colchicine	Colchicine	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Klor-Con	Potassium Chloride	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Cromolyn Sodium	Cromolyn Sodium	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Estradiol	Estradiol	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nizatidine	Nizatidine	11	suppressed
Victoza 2-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error